Rockefeller Capital Management
AGN

Rockefeller Capital Management’s Allergan plc AGN Stock Holding History

Rockefeller Capital Management’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-15,698
Closed -$2.78M – 2760
2020
Q1 		$2.78M Sell
15,698
-179
-1% -$33.7K 0.04% 289
2019
Q4 		$3.04M Buy
15,877
+544
+4% +$98.1K 0.04% 277
2019
Q3 		$2.58M Buy
15,333
+523
+4% +$85.2K 0.04% 258
2019
Q2 		$2.48M Sell
14,810
-4,342
-23% -$601K 0.03% 223
2019
Q1 		$2.8M Buy
19,152
+7,068
+58% +$1.02M 0.04% 215
2018
Q4 		$1.62M Buy
12,084
+11,997
+13,790% +$1.97M 0.03% 202
2018
Q3 		$17K Sell
87
-100
-53% -$18.4K ﹤0.01% 528
2018
Q2 		$32K Buy
+187
New +$30K ﹤0.01% 487

Other funds holding AGN

AJ
Ashburton (Jersey) St Helier, Jersey $227M AUM
C
Cerebellum San Francisco, California $21.5M AUM
B
Barings Charlotte, North Carolina $6.19B AUM 16.5% 1-Year Est. Return
JJ
JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

Rockefeller Capital Management's AGN Position: Q2 2020 in Review

Rockefeller Capital Management sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 15,698 shares — an estimated $2.78M sold.

Rockefeller Capital Management first reported a position in AGN in Q2 2018 and held it in 8 quarters. The position peaked at $3.04M in Q4 2019. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Rockefeller Capital Management reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Rockefeller Capital Management sold 15,698 Allergan plc shares in Q2 2020, an estimated $2.78M.
  • Rockefeller Capital Management first reported a position in Allergan plc in Q2 2018 and held it in 8 quarters.
  • Rockefeller Capital Management's Allergan plc position peaked at $3.04M in Q4 2019.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Rockefeller Capital Management's 13F filing for Q2 2020, filed 12 Aug 2020.